Evaluation of the Effects of Anti‐Aβ Antibody Drug Treatment on Brain Atrophy Using a Voxel‐Based Specific Regional Analysis System for Alzheimer's Disease
Our results demonstrated that the severity of VOI atrophy measured using VSRAD was significantly decreased in patients treated with lecanemab in actual clinical practice.
Authors
- Yuta Inagawa (ORCID: https://orcid.org/0009-0000-5792-5483)
- Haruo Hanyu (ORCID: https://orcid.org/0000-0003-4411-335X)
- Yuki MIYAGI
- Soichiro Shimizu (ORCID: https://orcid.org/0000-0003-1324-1973)
- Kazuhiro Saito (ORCID: https://orcid.org/0000-0001-5854-2070)
- Naoto Takenoshita
- Shoya Inagawa
- Tomohiko Sato
- Mana Yoshimura
Institutions
- Tokyo Medical University (JP)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_098835
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00